Company intelligence / Profile preview
Lipidor
- Ownership
- Private
- Employees
- ~9
- Development stage
- Phase 3
Overview
Lipidor develops novel lipid-based topical pharmaceuticals using its proprietary AKVANO technology. The company’s lead program has reached Phase III clinical trials as of March 2025. Its pipeline includes reformulated products for common dermatological conditions such as psoriasis and acne. The company partners with global pharma firms to accelerate the development and commercialization of innovative skin treatments.
- Therapeutic areas
- DermatologyInfectious Diseases
- Modalities
- Small molecule (reformulation of proven pharmaceutical substances)Nanoparticle (lipid-based delivery)Device (sprayable topical formulations)Biologic (potential for chemical and biological APIs via partnerships)
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Lipidor.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lipidor.